🔎 Trials Near Me

Akèy › Dematit atopik (Ekzema) › Texas › Dallas

Etid klinik pou Dematit atopik (Ekzema) nan Dallas, TX

8 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Ap rekriteEtid obsèvasyon
  • Reveal Research Institute - Dallas- Site Number : 8400012, Dallas
Laj 12 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Novartis Investigative Site, Dallas
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Ap rekriteFaz 2
  • Investigational Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07003425

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Enveda Investigative Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07643766

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Ap rekriteFaz 3
  • Dermatology Treatment and Research Center /ID# 265812, Dallas
  • Modern Research Associates /ID# 263852, Dallas
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Ap rekriteFaz 2
  • Dermatology Treatment and Research Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Ap rekriteEtid obsèvasyon
  • Galderma Investigational Site 8238, Dallas
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Ap rekriteFaz 1
  • Clinical Investigations of Texas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2025 · NCT06982352

Etid Dematit atopik (Ekzema) nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.